Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
bivirkning af natriumhyaluronat |
Causative agent |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
1 |
allergi over for natriumhyaluronat |
Causative agent |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 40 mg/50 ml blæreinstillation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
Sodium hyaluronate [anti-rheumatic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 10 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 10 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 2,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 15 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 10 mg/ml intraokulær injektionsvæske, i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 14 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 15 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 30 mg/1 ml + natriumchondroitinsulfat 40 mg/1 ml intraokulær injektionsvæske, i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 23 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
hyaluronatnatrium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 10 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,55 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 10 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,85 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 10 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 10 mg/ml intraokulær injektionsvæske, i fyldt injektionssprøjte a 0,55 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 10 mg/ml intraokulær injektionsvæskei fyldt injektionssprøjte a 0,85 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 10 mg/ml intraokulær injektionsvæske, i fyldt injektionssprøjte a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 14 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 15 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 23 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,6 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
povindon + natriumhyaluronat oral gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 60 mg/3 ml intraartikulær injektionsvæske, i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 1,2 % injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 1,2 % injektionsvæske, opløsning i fyldt injektionssprøjte a 0,8 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 3 % injektionsvæske, opløsning i fyldt injektionssprøjte a 0,6 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 10 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,4 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 1,6 % injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 1,6 % injektionsvæske, opløsning i fyldt injektionssprøjte a 0,8 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 10 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 2 % injektionsvæske, opløsning i fyldt injektionssprøjte a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 14 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,55 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 14 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,85 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
glycyrrhetinsyre + hyaluronatnatrium + polyvinylpyrrolidon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
glycyrrhetinsyre + hyaluronatnatrium + polyvinylpyrrolidon pulver til oral gel, pakke a 15 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 20 mg/2 ml intraartikulær injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
natriumhyaluronat 10 µg/ml øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
hyaluronatnatrium til oral anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
intraartikulær hyaluronatnatrium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
oftalmisk hyaluronatnatrium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
hyaluronatnatrium til parenteral anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
allergi over for natriumhyaluronat |
Causative agent |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
1 |
Sodium hyaluronate 10micrograms/mL conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
|
Product containing precisely sodium hyaluronate 8.5 milligram/0.85 milliliter conventional release solution for intraocular injection syringe (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium hyaluronate 8.5 milligram/0.85 milliliter conventional release solution for intraocular injection syringe (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium hyaluronate 5.5 milligram/0.55 milliliter conventional release solution for intraocular injection syringe (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium hyaluronate 5.5 milligram/0.55 milliliter conventional release solution for intraocular injection syringe (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium hyaluronate 10 milligram/1 milliliter conventional release solution for intraocular injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium hyaluronate 10 milligram/1 milliliter conventional release solution for intraocular injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Sodium hyaluronate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium hyaluronate 23 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium hyaluronate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium hyaluronate 23 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium hyaluronate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium hyaluronate 20 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium hyaluronate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium hyaluronate 20 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium hyaluronate |
Inferred relationship |
Some |
1 |
Sodium hyaluronate 10 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium hyaluronate |
Inferred relationship |
Some |
1 |
Sodium hyaluronate 10 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium hyaluronate |
Inferred relationship |
Some |
1 |